← Browse by Condition
Medical Condition

blood protein disorders

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT07075185 Phase 1
Recruiting

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Enrollment
40 pts
Location
Australia
Sponsor
Kelonia Therapeutics, Inc.
View Trial →